Phase II Study of Single-agent Bevacizumab in Japanese Patients with Recurrent Malignant Glioma†.
Nagane, Motoo; Nishikawa, Ryo; Narita, Yoshitaka; Kobayashi, Hiroyuki; Takano, Shingo; Shinoura, Nobusada; Aoki, Tomokazu; Sugiyama, Kazuhiko; Kuratsu, Junichi; Muragaki, Yoshihiro; Sawamura, Yutaka; Matsutani, Masao; Japanese Journal of Clinical Oncology, 2012, vol. 42, issue 10, p 887, ISSN 03682811. ISBN 14653621.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef